| scholarly article | Q13442814 |
| P50 | author | Diarmaid Hughes | Q38543763 |
| P2093 | author name string | Patricia Komp Lindgren | |
| Asa Karlsson | |||
| P2860 | cites work | DNA sequencing with chain-terminating inhibitors | Q22066207 |
| Mutations of Bacteria from Virus Sensitivity to Virus Resistance | Q24533278 | ||
| The complete genome sequence of Escherichia coli K-12 | Q27860542 | ||
| Vaccination with FimH adhesin protects cynomolgus monkeys from colonization and infection by uropathogenic Escherichia coli | Q28144457 | ||
| Mapping and sequencing of mutations in the Escherichia colirpoB gene that lead to rifampicin resistance | Q29395941 | ||
| Mutations in topoisomerase IV and DNA gyrase of Staphylococcus aureus: novel pleiotropic effects on quinolone and coumarin activity | Q33690598 | ||
| Characterization of grlA, grlB, gyrA, and gyrB mutations in 116 unrelated isolates of Staphylococcus aureus and effects of mutations on ciprofloxacin MIC. | Q33695982 | ||
| Overexpression of the marA or soxS regulatory gene in clinical topoisomerase mutants of Escherichia coli | Q33698034 | ||
| The mar regulon: multiple resistance to antibiotics and other toxic chemicals | Q33739371 | ||
| Molecular mechanisms that confer antibacterial drug resistance | Q33915635 | ||
| Rapid and simple determination of the Escherichia coli phylogenetic group | Q33919655 | ||
| Non-target gene mutations in the development of fluoroquinolone resistance in Escherichia coli | Q33979064 | ||
| Cloning and nucleotide sequence of the DNA gyrase (gyrA) gene from Mycoplasma hominis and characterization of quinolone-resistant mutants selected in vitro with trovafloxacin | Q33980747 | ||
| Increasing resistance to fluoroquinolones in escherichia coli from urinary tract infections in the netherlands | Q40753468 | ||
| A prospective study of risk factors for symptomatic urinary tract infection in young women. | Q44808632 | ||
| Nalidixic acid-resistant mutations of the gyrB gene of Escherichia coli | Q46102812 | ||
| Homologous recombination between the tuf genes of Salmonella typhimurium. | Q47826625 | ||
| High mutation frequencies among Escherichia coli and Salmonella pathogens | Q48057867 | ||
| Mutator dynamics in fluctuating environments. | Q52043835 | ||
| Association of organic solvent tolerance and fluoroquinolone resistance in clinical isolates of Escherichia coli. | Q52247046 | ||
| The ECO.SENS Project: a prospective, multinational, multicentre epidemiological survey of the prevalence and antimicrobial susceptibility of urinary tract pathogens--interim report. | Q53331404 | ||
| Relative contributions of the AcrAB, MdfA and NorE efflux pumps to quinolone resistance in Escherichia coli. | Q53939108 | ||
| Survey on antibiotic usage in the treatment of urinary tract infections. | Q54032265 | ||
| Quinolone resistance from a transferable plasmid. | Q54143628 | ||
| A close correlation between improvement of organic solvent tolerance levels and alteration of resistance toward low levels of multiple antibiotics in Escherichia coli. | Q54181140 | ||
| Role of mutator alleles in adaptive evolution. | Q54564129 | ||
| Costs and Benefits of High Mutation Rates: Adaptive Evolution of Bacteria in the Mouse Gut | Q56944626 | ||
| Highly Variable Mutation Rates in Commensal and Pathogenic Escherichia coli | Q56944671 | ||
| Mechanisms of fluoroquinolone resistance | Q74371163 | ||
| Molecular analysis of fluoroquinolone-resistance in Escherichia coli on the aspect of gyrase and multiple antibiotic resistance (mar) genes | Q74654645 | ||
| Analysis of the mutations involved in fluoroquinolone resistance of in vivo and in vitro mutants of Escherichia coli | Q78166633 | ||
| Genetic characterization of highly fluoroquinolone-resistant clinical Escherichia coli strains from China: role of acrR mutations | Q33982113 | ||
| Pathogenesis of urinary tract infections: an update | Q34070526 | ||
| Treatment options for acute uncomplicated cystitis in adults | Q34070531 | ||
| Mutator bacteria as a risk factor in treatment of infectious diseases | Q34113782 | ||
| An international survey of the antimicrobial susceptibility of pathogens from uncomplicated urinary tract infections: the ECO.SENS Project | Q34166158 | ||
| Regulation of bacterial drug export systems | Q34300836 | ||
| AcrAB efflux pump plays a major role in the antibiotic resistance phenotype of Escherichia coli multiple-antibiotic-resistance (Mar) mutants | Q34370243 | ||
| The rise and fall of mutator bacteria. | Q34392588 | ||
| High frequency of hypermutable Pseudomonas aeruginosa in cystic fibrosis lung infection. | Q34508854 | ||
| Prevalence of plasmid-mediated quinolone resistance | Q34823435 | ||
| Adverse drug reactions: implications for the development of fluoroquinolones | Q35110233 | ||
| Genetic evidence for a role of parC mutations in development of high-level fluoroquinolone resistance in Escherichia coli. | Q35123629 | ||
| Identification for mar mutants among quinolone-resistant clinical isolates of Escherichia coli. | Q35125674 | ||
| Contributions of individual mechanisms to fluoroquinolone resistance in 36 Escherichia coli strains isolated from humans and animals. | Q35128319 | ||
| Quinolone resistance locus nfxD of Escherichia coli is a mutant allele of the parE gene encoding a subunit of topoisomerase IV. | Q35131579 | ||
| Characterization of a mutation in the parE gene that confers fluoroquinolone resistance in Streptococcus pneumoniae | Q35136293 | ||
| Regulation of chromosomally mediated multiple antibiotic resistance: the mar regulon. | Q35138349 | ||
| Autoactivation of the marRAB multiple antibiotic resistance operon by the MarA transcriptional activator in Escherichia coli | Q35605343 | ||
| Role of the acrAB locus in organic solvent tolerance mediated by expression of marA, soxS, or robA in Escherichia coli | Q35631010 | ||
| Characterization of fluoroquinolone-resistant mutants of escherichia coli selected in vitro | Q35821472 | ||
| Genetics and regulation of outer membrane protein expression by quinolone resistance loci nfxB, nfxC, and cfxB | Q35836816 | ||
| marA locus causes decreased expression of OmpF porin in multiple-antibiotic-resistant (Mar) mutants of Escherichia coli | Q36223906 | ||
| Regulation of production of type 1 pili among urinary tract isolates of Escherichia coli | Q37013735 | ||
| Activities of trovafloxacin compared with those of other fluoroquinolones against purified topoisomerases and gyrA and grlA mutants of Staphylococcus aureus. | Q39471404 | ||
| In vivo increase in resistance to ciprofloxacin in Escherichia coli associated with deletion of the C-terminal part of MarR | Q39474394 | ||
| Enhanced expression of the multidrug efflux pumps AcrAB and AcrEF associated with insertion element transposition in Escherichia coli mutants Selected with a fluoroquinolone | Q39477158 | ||
| Absence of mutations in marRAB or soxRS in acrB-overexpressing fluoroquinolone-resistant clinical and veterinary isolates of Escherichia coli. | Q39477234 | ||
| Mutation in the DNA gyrase A Gene of Escherichia coli that expands the quinolone resistance-determining region | Q39478070 | ||
| DNA gyrase and topoisomerase IV are dual targets of clinafloxacin action in Streptococcus pneumoniae. | Q39559340 | ||
| High frequency of mutator strains among human uropathogenic Escherichia coli isolates. | Q39694657 | ||
| Quinolone-resistant mutants of escherichia coli DNA topoisomerase IV parC gene | Q39781656 | ||
| Organic solvent tolerance and antibiotic resistance increased by overexpression of marA in Escherichia coli | Q39801923 | ||
| Quinolone resistance-determining region in the DNA gyrase gyrA gene of Escherichia coli | Q39816339 | ||
| Quinolone resistance-determining region in the DNA gyrase gyrB gene of Escherichia coli | Q40087129 | ||
| P433 | issue | 10 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Escherichia coli | Q25419 |
| P304 | page(s) | 3222-3232 | |
| P577 | publication date | 2003-10-01 | |
| P1433 | published in | Antimicrobial Agents and Chemotherapy | Q578004 |
| P1476 | title | Mutation rate and evolution of fluoroquinolone resistance in Escherichia coli isolates from patients with urinary tract infections | |
| P478 | volume | 47 |
| Q41881440 | 'Supermutators' found amongst highly levofloxacin-resistant E. coli isolates: a rapid protocol for the detection of mutation sites |
| Q28551202 | A Transporter Interactome Is Essential for the Acquisition of Antimicrobial Resistance to Antibiotics |
| Q38966188 | A mechanism-based pharmacokinetic/pharmacodynamic model allows prediction of antibiotic killing from MIC values for WT and mutants |
| Q64122917 | A one health perspective on dairy production and dairy food safety |
| Q36836273 | Accumulation of mutants in "aging" bacterial colonies is due to growth under selection, not stress-induced mutagenesis |
| Q33805682 | Alterations in DNA gyrase and topoisomerase IV in resistant mutants of Clostridium perfringens found after in vitro treatment with fluoroquinolones |
| Q37704177 | Antibiotic resistance and its cost: is it possible to reverse resistance? |
| Q21144279 | Antimalarial therapy selection for quinolone resistance among Escherichia coli in the absence of quinolone exposure, in tropical South America |
| Q52360303 | Antimicrobial resistance (AMR) nanomachines-mechanisms for fluoroquinolone and glycopeptide recognition, efflux and/or deactivation. |
| Q36264490 | Antimicrobial resistance in the hospital setting: impact, trends, and infection control measures |
| Q37356533 | Antimicrobial resistance: its emergence and transmission |
| Q37263765 | Association of fluoroquinolone resistance, virulence genes, and IncF plasmids with extended-spectrum-β-lactamase-producing Escherichia coli sequence type 131 (ST131) and ST405 clonal groups. |
| Q27008535 | Bacterial Responses and Genome Instability Induced by Subinhibitory Concentrations of Antibiotics |
| Q33836664 | Biological cost of single and multiple norfloxacin resistance mutations in Escherichia coli implicated in urinary tract infections. |
| Q37894832 | Broad-specificity efflux pumps and their role in multidrug resistance of Gram-negative bacteria |
| Q47897914 | Can a pharmacokinetic/pharmacodynamic (PKPD) model be predictive across bacterial densities and strains? External evaluation of a PKPD model describing longitudinal in vitro data. |
| Q36905565 | Causes and consequences of DNA repair activity modulation during stationary phase in Escherichia coli |
| Q92051378 | Characterization of Mechanisms Lowering Susceptibility to Flumequine among Bacteria Isolated from Chilean Salmonid Farms |
| Q37157491 | Characterization of multiple-antimicrobial-resistant Escherichia coli isolates from diseased chickens and swine in China. |
| Q49841193 | Chromosomal mutations that accompany qnr in clinical isolates of escherichia coli |
| Q34104262 | Ciprofloxacin dosage and emergence of resistance in human commensal bacteria |
| Q54298880 | Ciprofloxacin resistance in E. coli isolated from turkeys in Great Britain. |
| Q46832047 | Comparison of the minimum inhibitory, mutant prevention and minimum bactericidal concentrations of ciprofloxacin, levofloxacin and garenoxacin against enteric Gram-negative urinary tract infection pathogens |
| Q37696851 | Compensation of fitness costs and reversibility of antibiotic resistance mutations |
| Q58756032 | Conserved collateral antibiotic susceptibility networks in diverse clinical strains of Escherichia coli |
| Q41810485 | Contribution of a new mutation in parE to quinolone resistance in extended-spectrum-beta-lactamase-producing Escherichia coli isolates |
| Q39674302 | Contribution of target alteration, protection and efflux pump in achieving high ciprofloxacin resistance in Enterobacteriaceae |
| Q36444536 | Contributions of mutations in acrR and marR genes to organic solvent tolerance in Escherichia coli |
| Q36295431 | Contributions of the combined effects of topoisomerase mutations toward fluoroquinolone resistance in Escherichia coli |
| Q36961674 | Controlling mutation: intervening in evolution as a therapeutic strategy |
| Q34487416 | Correlation of overexpression of efflux pump genes with antibiotic resistance in Escherichia coli Strains clinically isolated from urinary tract infection patients |
| Q28082095 | Costs of antibiotic resistance - separating trait effects and selective effects |
| Q36080959 | De Novo Characterization of Genes That Contribute to High-Level Ciprofloxacin Resistance in Escherichia coli |
| Q89907735 | Detection of Chromosomal and Plasmid-Mediated Quinolone Resistance Among Escherichia coli Isolated from Urinary Tract Infection Cases; Zagazig University Hospitals, Egypt |
| Q96022501 | Development and selection of low-level multi-drug resistance over an extended range of sub-inhibitory ciprofloxacin concentrations in Escherichia coli |
| Q40148534 | Digital PCR for Detection and Quantification of Fluoroquinolone Resistance in Legionella pneumophila. |
| Q43101882 | Draft Genome Sequences of Two Drug-Resistant Isolates of Pseudomonas aeruginosa Obtained from Keratitis Patients in India |
| Q38028573 | Dual-acting hybrid antibiotics: a promising strategy to combat bacterial resistance |
| Q54340974 | Editorial comment to genome-wide transcriptome analysis of fluoroquinolone resistance in clinical isolates of Escherichia coli. |
| Q43503778 | Effect of six fluoroquinolones on the expression of four efflux pumps in the multidrug resistant Escherichia coli isolates |
| Q40164392 | Emergence and spread of three clonally related virulent isolates of CTX-M-15-producing Escherichia coli with variable resistance to aminoglycosides and tetracycline in a French geriatric hospital |
| Q33556074 | Emergence of plasmid-mediated quinolone resistance in Escherichia coli in Europe |
| Q35023326 | Endocarditis caused by extended-spectrum-beta-lactamase-producing Klebsiella pneumoniae: emergence of resistance to ciprofloxacin and piperacillin-tazobactam during treatment despite initial susceptibility |
| Q39195574 | Environmental and genetic modulation of the phenotypic expression of antibiotic resistance |
| Q41624662 | Epidemic characterization and molecular genotyping of Shigella flexneri isolated from calves with diarrhea in Northwest China |
| Q37039694 | Epigenetic Influence of Dam Methylation on Gene Expression and Attachment in Uropathogenic Escherichia coli |
| Q28238561 | Evolution of mutation rates in bacteria |
| Q38543385 | Evolutionary consequences of drug resistance: shared principles across diverse targets and organisms |
| Q45737750 | Expression of TolC and Organic Solvent Tolerance of Escherichia Coli Ciprofloxacin Resistant Mutants |
| Q37494961 | Factors affecting the reversal of antimicrobial-drug resistance. |
| Q47725174 | Fitness cost constrains the spectrum of marR mutations in ciprofloxacin-resistant Escherichia coli |
| Q46921856 | Fluoroquinolone resistance linked to both gyrA and parC mutations in the quinolone resistance-determining region of Shigella dysenteriae type 1. |
| Q36871802 | Fluoroquinolone resistance mechanisms in an Escherichia coli isolate, HUE1, without quinolone resistance-determining region mutations |
| Q43062855 | Fluoroquinolone resistance mechanisms in multidrug-resistant Escherichia coli isolated from extraintestinal infections in dogs. |
| Q33910855 | Fluoroquinolone resistance mechanisms of Shigella flexneri isolated in Bangladesh. |
| Q33225318 | Fluoroquinolone-resistant Escherichia coli, Indonesia |
| Q39990097 | Fosfomycin and rifampin disk diffusion tests for detection of Escherichia coli mutator strains |
| Q95840911 | Genes and Proteomes Associated With Increased Mutation Frequency and Multidrug Resistance of Naturally Occurring Mismatch Repair-Deficient Salmonella Hypermutators |
| Q90574301 | Genetic Characterization of Antimicrobial-Resistant Escherichia coli Isolated from a Mixed-Use Watershed in Northeast Georgia, USA |
| Q43167548 | Genetic profiles of fluoroquinolone-resistant Escherichia coli isolates obtained from patients with cystitis: phylogeny, virulence factors, PAIusp subtypes, and mutation patterns |
| Q45044154 | Genetic relatedness of ciprofloxacin-resistant Shigella dysenteriae type 1 strains isolated in south Asia |
| Q33836661 | Genomics of rapid adaptation to antibiotics: convergent evolution and scalable sequence amplification |
| Q36106220 | Hidden Selection of Bacterial Resistance to Fluoroquinolones In Vivo: The Case of Legionella pneumophila and Humans |
| Q37282428 | High frequency of hotspot mutations in core genes of Escherichia coli due to short-term positive selection. |
| Q60922671 | High frequency of mutations in gene associated with quinolones resistance in uropathogenic isolates from the north of Iran |
| Q36410455 | High-throughput identification and rational design of synergistic small-molecule pairs for combating and bypassing antibiotic resistance |
| Q96609310 | Highly parallel lab evolution reveals that epistasis can curb the evolution of antibiotic resistance |
| Q33770211 | Hypermutable and fluoroquinolone-resistant clinical isolates of Staphylococcus aureus |
| Q51153258 | Impact of plasmid-borne oqxAB on the development of fluoroquinolone resistance and bacterial fitness in Escherichia coli. |
| Q52620715 | Improvement in organic solvent tolerance by double disruptions of proV and marR genes in Escherichia coli. |
| Q41623941 | In vitro selection of resistance to pradofloxacin and ciprofloxacin in canine uropathogenic Escherichia coli isolates |
| Q35758863 | Increased genome instability in Escherichia coli lon mutants: relation to emergence of multiple-antibiotic-resistant (Mar) mutants caused by insertion sequence elements and large tandem genomic amplifications |
| Q92538005 | Increasing Prevalence of ESBL-Producing Multidrug Resistance Escherichia coli From Diseased Pets in Beijing, China From 2012 to 2017 |
| Q43181792 | Induction and inhibition of ciprofloxacin resistance-conferring mutations in hypermutator bacteria |
| Q34073057 | Induction of resistant mutants of Salmonella enterica serotype Typhi under ciprofloxacin selective pressure |
| Q42861027 | Influence of inoculum size on the selection of resistant mutants of Escherichia coli in relation to mutant prevention concentrations of marbofloxacin |
| Q21146100 | Inhibition of mutation and combating the evolution of antibiotic resistance |
| Q28551361 | Integrating Antimicrobial Therapy with Host Immunity to Fight Drug-Resistant Infections: Classical vs. Adaptive Treatment |
| Q41220729 | Intensity and Mechanisms of Fluoroquinolone Resistance within the H30 and H30Rx Subclones of Escherichia coli Sequence Type 131 Compared with Other Fluoroquinolone-Resistant E. coli |
| Q42201141 | Interplay between plasmid-mediated and chromosomal-mediated fluoroquinolone resistance and bacterial fitness in Escherichia coli. |
| Q28475870 | Interplay in the selection of fluoroquinolone resistance and bacterial fitness |
| Q37052814 | Levofloxacin in the treatment of complicated urinary tract infections and acute pyelonephritis |
| Q57922545 | Low-Level Antimicrobials in the Medicinal Leech Select for Resistant Pathogens That Spread to Patients |
| Q28542920 | Mathematical modeling of bacterial kinetics to predict the impact of antibiotic colonic exposure and treatment duration on the amount of resistant enterobacteria excreted |
| Q54330643 | Mechanisms accounting for fluoroquinolone multidrug resistance Escherichia coli isolated from companion animals. |
| Q36155441 | Mechanisms of resistance to quinolones |
| Q50097364 | Methods to Determine Mutational Trajectories After Experimental Evolution of Antibiotic Resistance |
| Q40412595 | Molecular analysis of high-level ciprofloxacin resistance in Salmonella enterica serovar Typhi and S. Paratyphi A: need to expand the QRDR region? |
| Q39020968 | Mutation Supply and Relative Fitness Shape the Genotypes of Ciprofloxacin-Resistant Escherichia coli |
| Q46610974 | Mutations in the gyrA and parC genes in ciprofloxacin-resistant clinical isolates of Acinetobacter baumannii in Korea |
| Q34931378 | N-Benzyl-3-sulfonamidopyrrolidines are a New Class of Bacterial DNA Gyrase Inhibitors |
| Q92895032 | Next-generation strategy for treating drug resistant bacteria: Antibiotic hybrids |
| Q33836603 | Novel Ser79Leu and Ser81Ile substitutions in the quinolone resistance-determining regions of ParC topoisomerase IV and GyrA DNA gyrase subunits from recent fluoroquinolone-resistant Streptococcus pneumoniae clinical isolates |
| Q37735314 | Occurrence of urinary tract infection in adolescent and adult women of shanty town in Dhaka City, Bangladesh |
| Q36903693 | Optimizing drug exposure to minimize selection of antibiotic resistance |
| Q40666822 | Pharmacodynamic model to describe the concentration-dependent selection of cefotaxime-resistant Escherichia coli |
| Q64092139 | Phenotypic and genotypic characteristics of with non-susceptibility to quinolones isolated from environmental samples on pig farms |
| Q37364771 | Plasmid-Mediated Quinolone-Resistance (qnr) Genes in Clinical Isolates of Escherichia coli Collected from Several Hospitals of Qazvin and Zanjan Provinces, Iran. |
| Q40368674 | Plasmidic qnr Genes Confer Clinical Resistance to Ciprofloxacin under Urinary Tract Physiological Conditions. |
| Q37007127 | Polymorphic mutation frequencies in Escherichia coli: emergence of weak mutators in clinical isolates |
| Q89591629 | Population bottlenecks strongly influence the evolutionary trajectory to fluoroquinolone resistance in Escherichia coli |
| Q30397339 | Population structure of Japanese extraintestinal pathogenic Escherichia coli and its relationship with antimicrobial resistance |
| Q47123962 | Prevalence and characteristics of ST131 clone among unselected clinical Escherichia coli in a Chinese university hospital |
| Q38270541 | Prevalence of hypermutators among clinical Acinetobacter baumannii isolates |
| Q37798457 | Quinolone and cephalosporin resistance in enteric fever |
| Q36057372 | Quinolone resistance and ornithine decarboxylation activity in lactose-negative Escherichia coli. |
| Q36189712 | Quinolone-resistant Shigella flexneri isolated in a patient who travelled to India |
| Q43098014 | Quorum-sensing regulator sdiA and marA overexpression is involved in in vitro-selected multidrug resistance of Escherichia coli |
| Q83230169 | Rapid decline of bacterial drug-resistance in an antibiotic-free environment through phenotypic reversion |
| Q41913112 | Reduction of the fitness burden of quinolone resistance in Pseudomonas aeruginosa |
| Q41975822 | Relationships among ciprofloxacin, gatifloxacin, levofloxacin, and norfloxacin MICs for fluoroquinolone-resistant Escherichia coli clinical isolates |
| Q40597303 | Reversing bacterial resistance to antibiotics by phage-mediated delivery of dominant sensitive genes |
| Q54377726 | Risk factors and mechanisms of fluoroquinolone resistance in 156 Escherichia coli strains clinically isolated from urinary tract infections. |
| Q35059167 | Salmonella and Escherichia coli contamination of poultry meat from a processing plant and retail markets in Ibadan, Oyo State, Nigeria |
| Q38220609 | Selection and evolution of resistance to antimicrobial drugs |
| Q40968026 | Single-nucleotide polymorphism mutation spectra and resistance to quinolones in Salmonella enterica serovar Enteritidis with a mutator phenotype |
| Q90296284 | Soft sweep development of resistance in Escherichia coli under fluoroquinolone stress |
| Q42880673 | Study of Organic Solvent Tolerance and Increased Antibiotic Resistance Properties in E. coli gyrA Mutants |
| Q37049823 | Temporal changes in resistance mechanisms in colonizing Escherichia coli isolates with reduced susceptibility to fluoroquinolones |
| Q35606622 | The Goldilocks principle and antibiotic resistance in bacteria |
| Q26786956 | The Three Bacterial Lines of Defense against Antimicrobial Agents |
| Q54331161 | The first report of the qnrB19, qnrS1 and aac(6´)-Ib-cr genes in urinary isolates of ciprofloxacin-resistant Escherichia coli in Brazil. |
| Q98157764 | The prevalence and mechanism of fluoroquinolone resistance in Escherichia coli isolated from swine farms in China |
| Q33964949 | The prevalence of fluoroquinolone resistance mechanisms in colonizing Escherichia coli isolates recovered from hospitalized patients |
| Q39024870 | The role of RND efflux pump and global regulators in tigecycline resistance in clinical Acinetobacter baumannii isolates |
| Q36458378 | The treatment of urinary tract infections and use of ciprofloxacin extended release |
| Q37612974 | Tigecycline Nonsusceptibility Occurs Exclusively in Fluoroquinolone-Resistant Escherichia coli Clinical Isolates, Including the Major Multidrug-Resistant Lineages O25b:H4-ST131-H30R and O1-ST648. |
| Q37023257 | Urinary Tract Physiological Conditions Promote Ciprofloxacin Resistance in Low-Level-Quinolone-Resistant Escherichia coli. |
| Q43643443 | Vertical transmission of a fluoroquinolone-resistant Escherichia coli within an integrated broiler operation. |
| Q38665569 | Weak mutators can drive the evolution of fluoroquinolone resistance in Escherichia coli |
| Q47709543 | Whole-genome sequencing and genetic analysis reveals novel stress responses against individual constituents of essential oils in Escherichia coli. |
Search more.